These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3095143)

  • 21. Amyloid fibrils formed by selective N-, C-terminal sequences of mouse apolipoprotein A-II.
    Sawashita J; Kametani F; Hasegawa K; Tsutsumi-Yasuhara S; Zhang B; Yan J; Mori M; Naiki H; Higuchi K
    Biochim Biophys Acta; 2009 Oct; 1794(10):1517-29. PubMed ID: 19596087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of amino acid composition of glutamine-rich domains on amyloid formation and fragmentation.
    Alexandrov AI; Polyanskaya AB; Serpionov GV; Ter-Avanesyan MD; Kushnirov VV
    PLoS One; 2012; 7(10):e46458. PubMed ID: 23071575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of sequential proline substitutions on amyloid formation by human amylin20-29.
    Moriarty DF; Raleigh DP
    Biochemistry; 1999 Feb; 38(6):1811-8. PubMed ID: 10026261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pinpointing proline substitution to be responsible for the loss of amyloidogenesis in IAPP.
    Chakraborty S; Mukherjee B; Basu S
    Chem Biol Drug Des; 2013 Oct; 82(4):446-52. PubMed ID: 23758815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidized cholesterol metabolites found in human atherosclerotic lesions promote apolipoprotein C-II amyloid fibril formation.
    Stewart CR; Wilson LM; Zhang Q; Pham CL; Waddington LJ; Staples MK; Stapleton D; Kelly JW; Howlett GJ
    Biochemistry; 2007 May; 46(18):5552-61. PubMed ID: 17429947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of oxidation and mutation on the conformational dynamics and fibril assembly of amyloidogenic peptides derived from apolipoprotein C-II.
    Legge FS; Binger KJ; Griffin MD; Howlett GJ; Scanlon D; Treutlein H; Yarovsky I
    J Phys Chem B; 2009 Oct; 113(42):14006-14. PubMed ID: 19780547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro amyloid fibril formation by synthetic peptides corresponding to the amino terminus of apoSAA isoforms from amyloid-susceptible and amyloid-resistant mice.
    Kirschner DA; Elliott-Bryant R; Szumowski KE; Gonnerman WA; Kindy MS; Sipe JD; Cathcart ES
    J Struct Biol; 1998 Dec; 124(1):88-98. PubMed ID: 9931277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel amyloid fibril protein isolated from senescence-accelerated mice.
    Matsumura A; Higuchi K; Shimizu K; Hosokawa M; Hashimoto K; Yasuhira K; Takeda T
    Lab Invest; 1982 Sep; 47(3):270-5. PubMed ID: 6810021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mouse senile amyloid deposition is suppressed by adenovirus-mediated overexpression of amyloid-resistant apolipoprotein A-II.
    Chiba T; Kogishi K; Wang J; Xia C; Matsushita T; Miyazaki J; Saito I; Hosokawa M; Higuchi K
    Am J Pathol; 1999 Oct; 155(4):1319-26. PubMed ID: 10514414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spectroscopic studies of the tyrosine residues of human plasma apolipoprotein A-II.
    Massey JB; Pownall HJ
    Biochim Biophys Acta; 1989 Nov; 999(2):111-20. PubMed ID: 2512989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homologues of the human C and A apolipoproteins in the Macaca fascicularis (cynomolgus) monkey.
    Herbert PN; Bausserman LL; Lynch KM; Saritelli AL; Kantor MA; Nicolosi RJ; Shulman RS
    Biochemistry; 1987 Mar; 26(5):1457-63. PubMed ID: 3105581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A structural assessment of the apo[a] protein of human lipoprotein[a].
    Guevara J; Knapp RD; Honda S; Northup SR; Morrisett JD
    Proteins; 1992 Feb; 12(2):188-99. PubMed ID: 1318546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphism of apolipoprotein A-II (apoA-II) among inbred strains of mice. Relationship between the molecular type of apoA-II and mouse senile amyloidosis.
    Higuchi K; Kitagawa K; Naiki H; Hanada K; Hosokawa M; Takeda T
    Biochem J; 1991 Oct; 279 ( Pt 2)(Pt 2):427-33. PubMed ID: 1683229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I.
    von Eckardstein A; Funke H; Henke A; Altland K; Benninghoven A; Assmann G
    J Clin Invest; 1989 Dec; 84(6):1722-30. PubMed ID: 2512329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A structural core within apolipoprotein C-II amyloid fibrils identified using hydrogen exchange and proteolysis.
    Wilson LM; Mok YF; Binger KJ; Griffin MD; Mertens HD; Lin F; Wade JD; Gooley PR; Howlett GJ
    J Mol Biol; 2007 Mar; 366(5):1639-51. PubMed ID: 17217959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B133 (DSITKYFQMSLE), a laminin beta1-derived peptide, contains distinct core sequences for both integrin alpha2beta1-mediated cell adhesion and amyloid-like fibril formation.
    Katagiri F; Ohga Y; Takeyama K; Hozumi K; Kikkawa Y; Kadoya Y; Nomizu M
    Arch Biochem Biophys; 2010 Aug; 500(2):189-95. PubMed ID: 20452326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical study on the deposition of apolipoprotein E in cerebral and islet amyloidoses in cynomolgus monkeys (Macaca fascicularis).
    Nakamura S; Kiatipattanasakul W; Nakayama H; Ono F; Sakakibara I; Yoshikawa Y; Goto N; Doi K
    Exp Anim; 1996 Apr; 45(2):199-203. PubMed ID: 8726148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Codeposition of apolipoprotein A-IV and transthyretin in senile systemic (ATTR) amyloidosis.
    Bergström J; Murphy C; Eulitz M; Weiss DT; Westermark GT; Solomon A; Westermark P
    Biochem Biophys Res Commun; 2001 Jul; 285(4):903-8. PubMed ID: 11467836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure of cat islet amyloid polypeptide and identification of amino acid residues of potential significance for islet amyloid formation.
    Betsholtz C; Christmanson L; Engström U; Rorsman F; Jordan K; O'Brien TD; Murtaugh M; Johnson KH; Westermark P
    Diabetes; 1990 Jan; 39(1):118-22. PubMed ID: 2210054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The primary structure of high density apolipoprotein-glutamine-I.
    Baker HN; Delahunty T; Gotto AM; Jackson RL
    Proc Natl Acad Sci U S A; 1974 Sep; 71(9):3631-4. PubMed ID: 4372630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.